Location: Home
  • search
  • go
  • Relate News
  • 11/25/2025Samsung LS Fund Invests in Phrontline to Boost ADC Development
  • 11/25/2025CDE Solicits Comments on Draft Guidance for Computerized Systems and E...
  • 11/25/2025Kelun Reports Positive Phase 2 Results for Sac-TMT Combined with KEYTR...
  • 11/25/2025China Accelerates Investment in Nuclear Medicine Amid Global Radiophar...
  • 11/21/2025Innovent Moves Toward China Filing After High-Dose Obesity Drug Delive...
  • 11/21/2025Xiangxue Expands Into In Vivo TCR-T Therapy Through New Partnership
  • 11/21/2025Lynk Reports Positive Phase II Results for Topical JAK Inhibitor
  • 11/21/2025RocRock Biotech Raises CNY 50M to Advance Next-Gen CAR-M Therapies
  • 11/21/2025CSPC Advances Nectin-4 ADC SYS6002 Into First Phase 3 Trial
  • 11/21/2025NMPA Issues New Rules on Inspections and Export Certificates for Drug ...
  • 11/21/2025Recent Executive Moves
  • 11/21/2025US Report Flags Risks From China's Expanding Control of Pharma Supply ...
  • 11/21/2025China's Biopharma Innovation Surges — McKinsey Lays Out Both Opportun...
  • 11/20/2025China's Innovation-drug BD Boom Slows as Investors Shift Focus to Prod...
  • 11/20/2025China Biopharma Tracker – October 2025 (PharmaDJ)
  • 11/20/2025Nona Biosciences Teams Up With Pfizer for Next-Gen Antibody Discovery
  • 11/20/2025China's Pharmaceutical Market Enters a New Consumer-Driven Era
  • 11/20/2025CRO Boom Sweeps APAC as China Takes the Lead
  • 11/20/2025China Pilots Next-Generation AI Reforms Across Public Hospitals
  • 11/20/2025NHC Issues the Guidelines for Strengthening Service Capacity in Primar...
  • 11/20/2025GSK, LTZ Forge Strategic Alliance to Advance Novel Myeloid Cell Engage...
  • 11/20/2025Innovent's Mazdutide Achieves Strong Phase 3 Results in Chinese Obesit...
  • 11/19/2025China Accelerates Animal Testing in Ambitious Biotech Push
  • 11/18/2025​​​​​​​TandemAI Raises $22M in Series A Extension to Advance AI...
  • 11/18/2025Resight Secures CNY Multi-Millions in Angel Round
  • 11/18/2025Shimai Pharma's HKSE IPO Application Accepted
  • 11/18/2025Henlius and Organon Score First Interchangeable Biosimilar to Perjeta
  • 11/18/2025Akeso's First CNS Candidate Cleared for Alzheimer's Clinical Trials in...
  • 11/18/2025BrightGene to Increase Stake in Suzhou GeekGene with CNY 50M Capital I...
  • 11/18/2025Zelgen Targets HKSE Main Board Listing, Plans to Wind Down U.S. Subsid...
  • Page:4/805 Total number of articles:24122: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group